Tag: post-market surveillance
FDA Sentinel Initiative: How Big Data Detects Drug Safety Issues
The FDA Sentinel Initiative uses big data from millions of patient records to detect hidden drug risks in real time, replacing outdated reporting systems with active, science-driven safety monitoring.
Continue Reading